2000-2017年全球区域麻疹消除进展
该报告描述了2000-2017年全球麻疹控制里程碑和区域消除目标的进展。期间全球MCV1覆盖率从72%升至85%,报告发病率下降83%,估算死亡下降80%,但消除里程碑未达成且三个区域出现大规模复燃。
要点
- 2000-2017年全球MCV1覆盖率从72%升至85%,麻疹报告发病率下降83%。
- 消除里程碑未达成,三个WHO区域出现大规模麻疹复燃。
核心结论
- 全球麻疹控制取得进展但消除里程碑未达成,三个区域出现大规模复燃。
- 需加强基于病例的监测并提高MCV1和MCV2覆盖率以推进消除目标。
研究设计与样本
- 基于全球报告数据的进展描述性分析,更新既往报告,覆盖2000-2017年。
主要发现
- 2000-2017年全球估算MCV1覆盖率从72%升至85%。
- 年报告麻疹发病率下降83%,从145降至25例/百万人口。
- 年估算麻疹死亡下降80%,从545,174降至109,638。
- 消除里程碑未达成,三个区域正经历大规模麻疹复燃。
关键数值与推荐
- 2010年世界卫生大会设定2015年里程碑:国家层面1岁儿童MCV1常规覆盖≥90%,每个地区≥80%。
- 2010年里程碑包括全球年麻疹发病率降至<5例/百万人口。
- 2010年里程碑包括全球麻疹死亡较2000年估算下降95%。
- 2012年GVAP目标为2015年六个WHO区域中四个消除麻疹,2020年五个区域消除。
- 所有六个WHO区域国家已采纳2020年麻疹消除目标。
临床怎么用
- 加强基于病例的麻疹监测以支持消除目标推进。
- 提高MCV1和MCV2覆盖率以应对复燃和未达里程碑。
- 维持政治承诺并确保实质性、持续的投资以实现全球和区域消除目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2010, the World Health Assembly set three milestones for measles prevention to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the national level and to ≥80% in every district; 2) reduce global annual measles incidence to less than five cases per million population; and 3) reduce global measles mortality by 95% from the 2000 estimate (1).* In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP),† with the objective of eliminating measles§ in four of the six World Health Organization (WHO) regions by 2015 and in five regions by 2020. Countries in all six WHO regions have adopted goals for measles elimination by 2020. This report describes progress toward global measles control milestones and regional measles elimination goals during 2000-2017 and updates a previous report (2). During 2000-2017, estimated MCV1 coverage increased globally from 72% to 85%; annual reported measles incidence decreased 83%, from 145 to 25 cases per million population; and annual estimated measles deaths decreased 80%, from 545,174 to 109,638. During this period, measles vaccination prevented an estimated 21.1 million deaths. However, measles elimination milestones have not been met, and three regions are experiencing a large measles resurgence. To make further progress, case-based surveillance needs to be strengthened, and coverage with MCV1 and the second dose of measles-containing vaccine (MCV2) needs to increase; in addition, it will be important to maintain political commitment and ensure substantial, sustained investments to achieve global and regional measles elimination goals.
引用
- Dabbagh A, Laws RL, Steulet C, et al. Progress Toward Regional Measles Elimination - Worldwide, 2000-2017. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30496160. doi:10.15585/mmwr.mm6747a6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。